EIS 4363
Alternative Names: EIS-4363Latest Information Update: 10 Nov 2023
Price :
$50 *
At a glance
- Originator Eisbach Bio
- Class Antivirals; Small molecules
- Mechanism of Action RNA helicase inhibitors
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity Yes
Highest Development Phases
- Preclinical COVID 2019 infections